← Full purpura and petechiae algorithm
Reasoning GP · Algorithm · 1-page summary

Purpura and petechiae

For: children and adults with a non-blanching rash, petechiae or purpura, in hours or OOH. Not for: ongoing specialist care of ITP, ANCA vasculitis or meningococcal survivors (haematology-, rheumatology- or hospital-led; detail in the full algorithm).
Reviewed October 2026 · next review April 2027
NICE NG240NG12NG143CG89BSH
Core rule: an unwell patient with a non-blanching rash has suspected meningococcal disease: 999 first, never wait for blood results. The glass test helps, but a rash that fades excludes nothing.

0Stop — call 999 now — and pre-alert

  • Non-blanching rash + fever + unwell; purpura >2 mm, a rapidly spreading non-blanching rash, or meningitis features with a non-blanching rash → 999
  • Purpura with haemodynamic compromise (pale, mottled, cold peripheries, prolonged capillary refill, altered consciousness): purpura fulminans / DIC → 999
  • Suspected TTP/HUS (low platelets + anaemia/haemolysis, renal impairment or neurology); major GI, intracranial or concealed bleeding; febrile neutropenia or severe pancytopenia; meningism, severe headache or seizures → 999
  • While waiting: meningococcal disease strongly suspected → IV/IM ceftriaxone (preferred) or benzylpenicillin as soon as possible, unless it delays transfer or severe allergy to that drug (benzylpenicillin <1 yr 300 mg · 1–9 yrs 600 mg · ≥10 yrs 1200 mg; doses per BNF/BNFC). No test may delay transfer.

1Triage — well or unwell decides first

PatientAction
UnwellPetechiae or purpura anywhere, or any abnormal vital sign → 999
ChildUnexplained petechiae or hepatosplenomegaly → Same-day immediate specialist assessment (NG12)
FBCPlatelets <20 × 10⁹/L, blasts or pancytopenia → Same-day haematology; significant bleeding → 999
SafeguardingPre-mobile infant, unexplained or implausible lesions → Urgent paediatric / safeguarding assessment; body map
WellFace/neck only after coughing, vomiting or crying → possible Valsalva; exclusion diagnosis (block 5)

2Screen — one row is enough

  • Leukaemia: child with pallor, persistent fatigue, unexplained fever, persistent infection, generalised nodes, bone pain, unexplained bruising or bleeding; adult with purpura + pallor, nodes or hepatosplenomegaly → Very urgent FBC ≤48 h
  • IgA vasculitis with severe abdominal pain, GI bleeding, cannot mobilise, hypertension, significant proteinuria or haematuria, renal impairment, dehydration → Same-day paediatrics
  • Palpable purpura with renal, respiratory, neurological or systemic features (ANCA vasculitis) → Urgent assessment
  • On heparin, suspected HIT → stop heparin now, non-heparin anticoagulant → Same-day haematology

3Assess — observations before anything else

☐ Temperature, HR, BP, RR, SpO₂, capillary refill, peripheral temperature, mental state  ☐ Glass test; conjunctivae and all skin incl. nappy area (harder to see on brown or black skin)  ☐ Palpable? Spreading? Mucosal bleeding?  ☐ Nodes, liver, spleen, joints, fundi

Well: FBC + film; clotting if bleeding significant or unexplained; urinalysis + renal function if vasculitis possible. No routine ANCA/ANA/EBV panels.

4Classify — only if blocks 0–2 are negative

  • ITP — well, isolated low platelets, normal Hb, white cells and film. Exclude leukaemia, drugs, TTP/HUS; haematology-led.
  • IgA vasculitis — age 3–15, palpable purpura on buttocks and legs, joint and abdominal pain. BP + urinalysis every review.
  • Valsalva / viral — well child; face and neck after a clear trigger, or palatal petechiae.
  • Actinic purpura — older adult, sun-exposed forearms and hands, normal FBC. Reassure; review medication.
  • Uncertain — say so. Diagnostic uncertainty with low platelets → same-day specialist discussion.

5Treat today — only these

  • Valsalva petechiae: only if observations normal, whole child examined, rash not spreading, drugs, platelets and safeguarding considered → reassure; review within 24 h.
  • IgA vasculitis, well: analgesia, fluids; avoid ibuprofen (or discuss) if renal impairment, dehydration, GI bleeding or significant proteinuria. No routine steroids.
  • Low platelets: avoid NSAIDs and aspirin; activity advice per haematology.
  • Drug cause: stop essential medicines only after assessing risk (except HIT). Doses: NICE/SPC, BNF, local formulary.

6Refer routinely

  • IgA vasculitis: urine and BP over several months; persistent proteinuria, hypertension or renal impairment → nephrology.
  • Unexplained thrombocytopenia not clearly ITP → haematology (suspected cancer pathway).
  • After meningococcal disease: audiology within 4 weeks of being well enough; notify the HPT, which arranges contact prophylaxis.

7Never reassure by

  • A rash that fades, or a negative or unclear glass test.
  • No fever in an infant or immunocompromised patient, or no rash.
  • Petechiae confined to the face and neck, on distribution alone.
  • An earlier label of ITP, viral petechiae or vasculitis once new fever or deterioration appears.
  • Waiting for blood results in an unwell patient.
  • A possible bleeding disorder when there are safeguarding concerns.

8Safety-net — say it, write it, document it

999 “Call 999 if a fever starts, the rash spreads or the spots get bigger, your child becomes drowsy, pale or unwell, or there is a severe headache, a fit, heavy bleeding, or dark urine or no urine.” Same day “Contact us today for new bleeding, tummy pain, joint pain, less urine, or pink or red urine with IgA vasculitis.”

A rash that fades does not rule out serious illness. On brown or black skin, check paler areas and inside the eyelids.

✓Safe to leave primary care only if — all five, documented

Observations normal; whole skin examined No block 0–2 row applies Cause explains the rash, or uncertainty discussed the same day Safeguarding considered and recorded Written safety-net given; review booked
Summary of the full Reasoning GP purpura and petechiae algorithm, which holds the detail, examination, differential and evidence. Sources: NICE NG240, NG12 (updated April 2026), NG143, CG89; BSH ITP and child-protection bleeding guidance; UKHSA meningococcal guidance and Green Book. Clinical reference — follow local emergency-transfer and safeguarding policies and check doses: NICE/SPC, BNF.